Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...

The pharma index fell 2.7%, while the benchmark Nifty ended 1.1% lower on Monday. The relationship between a decline in the rupee and better margins for IT companies is well known. What is not ...

The occasion was the 2025 PRWeek Healthcare Awards, a celebration of the sector that crafts the public’s perception of pharmaceutical companies, hospitals, health care insurers and care ...

Company executives ... recent and forecast pharmaceutical sales, market demand profiles, clinical trial, and drug approval procedures, regulatory policies, pricing and reimbursement regulations ...

Go to source) according to a report by McKinsey & Company. The report highlights rapid production expansion and growing capabilities in active pharmaceutical ingredients (APIs) and biotechnology ...

Other equities analysts have also recently issued reports about the company. Bank of America lifted their price target on BioMarin Pharmaceutical from $99.00 to $103.00 and gave the stock a “buy ...

For years, Jeff Simmons — the president and CEO of the large US pharmaceutical company Elanco — ridiculed a seemingly unlikely target on social media: the plant-based meat industry.